The NCI SBIR Program recently announced 14 new contract funding opportunities in a range of novel technology areas. To view the FY2016 Contract Topics Solicitation, visit: (PDF). For more information about this solicitation please see the Guide Notice NOT-OD-15-130 .
To download the appropriate forms for Phase I, Phase II, Direct-to-Phase II and Fast-Track proposals, please visit: http://grants.nih.gov/grants/forms.htm#contracts. Direct-to-Phase II SBIR proposals must be prepared in accordance with the Phase II proposal preparation instructions.
The deadline for receipt of all FY2016 contract topic proposals is October 16, 2015 by 5:00 PM ET.
*Please note, NCI now accepts submissions electronically.
HHS will hold a pre-proposal conference, via webinar, on August 13, 2015 at 2:00 PM Eastern Daylight Time. This informational webinar will discuss this solicitation, and in particular will discuss the new electronic contract proposal submission (eCPS) website.
Register for the webinar at: https://attendee.gotowebinar.com/register/1204029371162972674 . Following registration, a confirmation e-mail will be sent containing information about joining the webinar.
Presentation material from this webinar will be posted on FedBizOpps and the NIH SBIR/STTR webpage following its completion.
NIH/NCI 341: Development of Metabolomics Data Integration Methods and Software
NIH/NCI 342: Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention
NIH/NCI 343: An Electronic Platform for Cognitive Assessment in Cancer Patients
NIH/NCI 344: Technologies for Differential Isolation of Exosomes and Oncosomes
NIH/NCI 345: Predictive Biomarkers of Adverse Reactions to Radiation Treatment
NIH/NCI 346: Molecularly Targeted Radiation Therapy For Cancer Treatment
NIH/NCI 347: Signal Amplification to Enable Attomolar Quantitation in Slide-Based or ELISA Biomarker Immunoassays
NIH/NCI 348: Identification and Capture of Enriched Tumor Zones with Preservation of Labile Biomarkers from Ultra-Cold Biopsies
NIH/NCI 349: Proximity Slide Based Sandwich Immunoassay to Visualize Intramolecular Epitopes of Analytes in Tissue Sections
NIH/NCI 350: Highly Innovative Tools for Quantifying Redox Effector Dynamics in Cancer
NIH/NCI 351: Modulating the Microbiome to Improve Efficacy of Cancer Therapeutics
NIH/NCI 352: Cell and Animal-Based Models to Advance Cancer Health Disparity Research
NIH/NCI 353: Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis
NIH/NCI 354: Companion Diagnostics for Cancer Immunotherapies
If you have questions about any of the topics or general questions on contract administration, please contact:
Ms. Rosemary M. Hamill
Please reference solicitation PHS 2016-1 and the Topic number with any questions. Learn more about the difference between SBIR contracts and grants by clicking here.
View past contract opportunities.
This site is undergoing remediation for compliance with Section 508. The remediation will be complete by July 31, 2015.
In the interim, should you require any accessibility assistance with any content, please contact NCI SBIR & STTR